HLA-A*01 is Associated with Late Onset of Alzheimer's Disease in Italian Patients

In this study, the distribution of HLA-A alleles was analyzed in Italian Alzheimer's Disease (AD) patients. Interaction between HLA alleles, APOE genotypes, age of onset, and gender were also analyzed. The results were compared to those obtained in healthy controls (HC). One hundred-seventy-three AD patients and 258 age-and-sex-matched healthy controls were enrolled in the study. AD patients were classified according to age at the onset of disease using quartiles of the distribution. HLA-A genotyping was performed by PCR-SSP; APOE genotyping was performed by RFLP. A correlation between late disease onset and HLA-A*01 was observed. Thus, HLA-A*01, calculated as number of alleles, was significantly more present in patients with age of onset > 74 years than in HC (20% vs 10.5%; p=0.014); the distribution of this allele was skewed also in patients 68.1–74.0 years of age (16.3%), even if the difference did not reach statistical significance. The relative risk ratio (RRR) of AD onset calculated by a multinomial logistic regression adjusted for sex and presence of APOE-4 confirmed a significant association of HLA-A*01 with AD onset > 74.0 years of age (RRR=2.2; 95%CI: 1.1 – 4.6; p=0.033). A high RRR (2.04) was also present in patients 68.1 – 74 years (p=0.064). Lower age of disease onset did not correlate with HLA-A*01. Data herein suggest that the presence of HLA-A*01 results in delayed AD development, even in patients carrying APOE-4. These results could offer new insights into the etiopathogenesis of Alzheimer's disease.

[1]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[2]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.

[3]  D. T. Vernier,et al.  Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. , 1990, Journal of lipid research.

[4]  O. Olerup,et al.  HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. , 1992, Tissue antigens.

[5]  A. Kaszniak,et al.  Clinical trial of indomethacin in Alzheimer's disease , 1993, Neurology.

[6]  J. Haines,et al.  Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. , 1993, Science.

[7]  M. Pericak-Vance,et al.  Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[8]  G. Schellenberg,et al.  Evidence for association of HLA-A2 allele with onset age of Alzheimer's disease , 1997, Neurology.

[9]  S. Sorbi,et al.  HLA A2 allele is associated with age at onset of Alzheimer's disease , 1999, Annals of neurology.

[10]  G. Wenk,et al.  Peripheral administration of novel anti-inflammatories can attenuate the effects of chronic inflammation within the CNS , 1999, Brain Research.

[11]  M. Owen,et al.  A full genome scan for late onset Alzheimer's disease , 1999 .

[12]  P. Ince,et al.  Frequency of HLA-A and B alleles in early and late-onset Alzheimer's disease , 1999, Neuroscience Letters.

[13]  D. Clair,et al.  Human leucocyte antigen-A2 increases risk of Alzheimer's disease but does not affect age of onset in a Scottish population , 2000, Neuroscience Letters.

[14]  C. Caruso,et al.  A genetically determined high setting of TNF-alpha influences immunologic parameters of HLA-B8,DR3 positive subjects: implications for autoimmunity. , 2001, Human immunology.

[15]  I. Doxiadis,et al.  Protective and susceptible HLA polymorphisms in IgA nephropathy patients with end-stage renal failure. , 2001, Tissue antigens.

[16]  P. Zandi,et al.  Do NSAIDs prevent Alzheimer’s disease? And, if so, why? The epidemiological evidence , 2001, Neurobiology of Aging.

[17]  G. Schellenberg,et al.  HLA-A2 homozygosity but not heterozygosity is associated with Alzheimer disease , 2002, Neurology.

[18]  J. Lambert,et al.  No association of the HLA-A2 allele with Alzheimer's disease , 2002, Neuroscience Letters.

[19]  J. Molinuevo,et al.  Frequency of mutations in the presenilin and amyloid precursor protein genes in early-onset Alzheimer disease in Spain. , 2002, Archives of neurology.

[20]  [Association between the A2 allele of the HLA system and age at onset of Alzheimer's disease]. , 2003, Presse medicale.

[21]  M. Wozniak,et al.  Do infectious agents play a role in dementia? , 2003, Trends in microbiology.

[22]  C. Caruso,et al.  Major histocompatibility complex and sporadic Alzheimer's disease: a critical reappraisal , 2004, Experimental Gerontology.

[23]  W. Mayr,et al.  Distribution of HLA Class I Alleles Differs in Celiac Disease Patients According to Age of Onset , 2003, Digestive Diseases and Sciences.

[24]  E. Vellenga,et al.  Association with HLA class I in Epstein-Barr-virus-positive and with HLA class III in Epstein-Barr-virus-negative Hodgkin's lymphoma , 2005, The Lancet.

[25]  J. Becker,et al.  HLA-B8 association with late-stage melanoma – an immunological lesson? , 2006, BMC medicine.

[26]  C. Franceschi,et al.  Association between the HLA-A2 allele and Alzheimer disease. , 2006, Rejuvenation research.

[27]  J. Rogers,et al.  Inflammation, anti-inflammatory agents and Alzheimer disease: the last 12 years. , 2006, Journal of Alzheimer's disease : JAD.

[28]  G. T. te Meerman,et al.  HLA-A*02 is associated with a reduced risk and HLA-A*01 with an increased risk of developing EBV+ Hodgkin lymphoma. , 2007, Blood.

[29]  Philippe Amouyel,et al.  Genetic heterogeneity of Alzheimer's disease: Complexity and advances , 2007, Psychoneuroendocrinology.

[30]  E. Hasanoǧlu,et al.  HLA class 1 associations in Henoch Schonlein purpura: increased and decreased frequencies , 2007, Clinical Rheumatology.

[31]  C. Caruso,et al.  Genetic Control of Immune Response in Carriers of the 8.1 Ancestral Haplotype , 2007, Annals of the New York Academy of Sciences.

[32]  Roger N Rosenberg,et al.  Genome-wide association studies in Alzheimer disease. , 2008, Archives of neurology.

[33]  Allyson Hall,et al.  Predictors of injury among younger and older adults in fatal motor vehicle crashes. , 2008, Accident; analysis and prevention.

[34]  M. Franceschi,et al.  Association study of the HLA-A2 allele in Italian Alzheimer disease patients , 2009, Neurobiology of Aging.